Literature DB >> 6986551

Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients.

J M Sosenko, J L Breslow, O S Miettinen, K H Gabbay.   

Abstract

We explored the relation of plasma lipid levels to the degree of blood glucose control in young, insulin-dependent diabetic patients. Levels of total plasma cholesterol and triglyceride, of their lipoprotein subfractions, and of hemoglobin A, and fasting blood glucose were measured repeatedly over a one-year period in 105 patients. Lipid levels were also measured in 74 nondiabetic siblings. Increasingly poor control of diabetes, reflected by levels of hemoglobin A1 or of fasting blood glucose, was associated with statistically significant increases in total cholesterol (P less than or equal to 0.01), total triglyceride (P less than or equal to 0.007), and lipoprotein subfractions except for high-density lipoprotein cholesterol. Diabetic patients in best control had lipid levels similar to those in their nondiabetic siblings. These data on the relation of plasma lipid levels to diabetic control lend credence to the hypothesis that poor control of blood glucose is conducive to accelerated atherosclerosis in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986551     DOI: 10.1056/NEJM198003203021202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  29 in total

Review 1.  Treatment of diabetes: the effect on serum lipids and lipoproteins.

Authors:  P K Merrin; R S Elkeles
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats.

Authors:  P S Babu; K Srinivasan
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Amy S Shah; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; Franziska K Bishop; David M Maahs; Lawrence M Dolan; Clary B Clish; Sudha B Biddinger
Journal:  J Clin Lipidol       Date:  2019-09-25       Impact factor: 4.766

4.  Relationship between metabolic control and HDL2-cholesterol in type I diabetic patients.

Authors:  L Beccaria; D Sommariva; F Meschi; M G Boga; A Branchi; I Pogliaghi; C Ottomano; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

5.  Lack of a lipoprotein-induced insulin resistance in hepatoma cells in culture.

Authors:  F Rinninger; B Wolf; H U Haering; W Bachmann
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

6.  Evidence for functional endothelial cell damage in early diabetic retinopathy.

Authors:  M Porta; C Townsend; G M Clover; M Nanson; A R Alderson; A McCraw; E M Kohner
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

7.  Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit.

Authors:  H C Huang; Y I Weng; C R Lee; T R Jan; Y L Chen; Y T Lee
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

8.  Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Owerbach; S Gunn; G Ty; L Wible; K H Gabbay
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

9.  Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells.

Authors:  S Aanderud; H Krane; A Nordøy
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

10.  Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.

Authors:  R B Goldberg; M L Reeves; D E Seigler; E A Ryan; N Miller; S L Hsia; J S Skyler
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.